Larimar Therapeutics (LRMR) Short-term Investments: 2014-2020
Historic Short-term Investments for Larimar Therapeutics (LRMR) over the last 5 years, with Sep 2020 value amounting to $1.0 million.
- Larimar Therapeutics' Short-term Investments fell 97.41% to $1.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.0 million, marking a year-over-year decrease of 97.41%. This contributed to the annual value of $43.0 million for FY2019, which is 37.37% down from last year.
- Larimar Therapeutics' Short-term Investments amounted to $1.0 million in Q3 2020, which was down 0.99% from $1.0 million recorded in Q2 2020.
- Over the past 5 years, Larimar Therapeutics' Short-term Investments peaked at $134.7 million during Q1 2016, and registered a low of $1.0 million during Q3 2020.
- Its 3-year average for Short-term Investments is $41.9 million, with a median of $43.0 million in 2019.
- Its Short-term Investments has fluctuated over the past 5 years, first skyrocketed by 57.46% in 2019, then slumped by 98.14% in 2020.
- Over the past 5 years, Larimar Therapeutics' Short-term Investments (Quarterly) stood at $96.8 million in 2016, then crashed by 36.73% to $61.3 million in 2017, then increased by 12.17% to $68.7 million in 2018, then plummeted by 37.37% to $43.0 million in 2019, then crashed by 97.41% to $1.0 million in 2020.
- Its last three reported values are $1.0 million in Q3 2020, $1.0 million for Q2 2020, and $24.9 million during Q1 2020.